# An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)

> **NCT00744757** · PHASE2 · COMPLETED · sponsor: **Johnson & Johnson Taiwan Ltd** · enrollment: 37 (actual)

## Conditions studied

- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT00744757
- **Lead sponsor:** Johnson & Johnson Taiwan Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-09
- **Final completion:** 2012-08
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2013-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00744757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00744757, "An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00744757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*